Join to view full profile
9555 Upland Ln NMaple Grove, MN 55369
Phone+1 952-993-1440
Fax+1 763-581-5401
Dr. Carlson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Geisinger Health System (Danville)Fellowship, Cardiovascular Disease, 2008 - 2011
Hennepin HealthcareResidency, Internal Medicine, 2005 - 2008
University of Minnesota Medical SchoolClass of 2005
Certifications & Licensure
IA State Medical License 2024 - 2027
MN State Medical License 2011 - 2026
WI State Medical License 2011 - 2015
PA State Medical License 2008 - 2011
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012-2017
Publications & Presentations
PubMed
- 6 citationsIntegrated smoking cessation and mood management following acute coronary syndrome: Protocol for the post-acute cardiac event smoking (PACES) trial.Melissa Adkins-Hempel, Sandra J Japuntich, Michelle Chrastek, Shira Dunsiger, Christopher E Breault
Addiction Science & Clinical Practice. 2023-05-12 - 55 citationsRetinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair ProteinsGaspar J. Kitange, Ann C. Mladek, Mark A. Schroeder, Jenny C. Pokorny, Brett L. Carlson
Cell Reports. 2016-03-22 - 18 citationsFactors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for O...Shruthi Vaidhyanathan, Brynna Wilken-Resman, Daniel J. Ma, Karen E. Parrish, Rajendar K. Mittapalli
The Journal of Pharmacology and Experimental Therapeutics. 2016-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
